Citation Impact
Citing Papers
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
2008 Standout
Endocan: A novel inflammatory indicator in cardiovascular disease?
2015 Standout
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016 Standout
Gut Microbiota, Host Organism, and Diet Trialogue in Diabetes and Obesity
2019
Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities
2021 Standout
Clinical Trials with Oncolytic Adenovirus in China
2007
A meta-analysis of randomized controlled trials comparing carboplatin-based to cisplatin-based chemotherapy in advanced non-small cell lung cancer
2007
Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes
2004
The first 30 years of p53: growing ever more complex
2009 Standout
Effect of Non‐Surgical Periodontal Treatment on Gingival Crevicular Fluid and Serum Endocan, Vascular Endothelial Growth Factor‐A, and Tumor Necrosis Factor‐Alpha Levels
2016
Endocan, Novel Potential Biomarker for Systemic Sclerosis: Results of a Pilot Study
2015
The Influence of Probiotics on the Firmicutes/Bacteroidetes Ratio in the Treatment of Obesity and Inflammatory Bowel disease
2020 Standout
Works of Cornelia Niţipir being referenced
Gemcitabine (GEM) and carboplatin (CBDCA) versus cisplatin (CDDP) and vinblastine (VLB) in advanced non-small-cell lung cancer (NSCLC) stages III and IV: a phase III randomised trial
2002
Serum Endocan Levels are Increased in Patients with Inflammatory Bowel Disease
2013
Gut Microbiota Patterns in Obese and Type 2 Diabetes (T2D) Patients from Romanian Black Sea Coast Region
2018